Therapeutic Effect of Transmyocardial Laser Revascularization Combined with VEGF Gene on Collateral Circulation for Myocardial Ischemia

雷莉,郭静萱,张萍,孙威,冯新恒,陈凤荣,毛节明

DOI: https://doi.org/10.3969/j.issn.1001-6325.2001.03.006

2001-01-01

Abstract:Objective To investigate whether transmyocardial laser revascularization (TMLR) combined with vascular endothelial growth factor (VEGF) gene therapy may further angiogenesis induced by TMLR alone. Methods Acute myocardial ischemia was created in procine hearts by ligating left anterior descending artery with preceding ischemia preconditioning. Twelve pigs were randomized to TMLR+VEGF group ( n = 7) or TMLR alone group ( n = 5). Four to five transmural channels were performed on ischemic myocardium with Nd:YAG laser (λ=1 064 nm). Optical fiber diameter was 1 000 μm. Intramyocardial injections were placed in the vicinity of channels. The TMLR+VEGF group used pcD2/VEGF 121 expression plasmid (800 μl, 2 5 mg/ml). The TMLR alone group used sterile distilled water (800 μl). Animals were sacrificed 4 weeks or 8 weeks post therapy. VEGF mRNA was detected with RTPCR. VEGF protein was detected with immunohistochemistry. Blood vessels were stained with alkaline phosphatase histochemistry. Results TMLR+VEGF group has a significant higher level of VEGF mRNA and protein expression compared with TMLR alone group 4 weeks post therapy. Eight weeks post therapy VEGF mRNA and protein decreased significantly in both groups. Vascular density was significantly elevated in TMLR+VEGF group compared with TMLR alone group (4 weeks post therapy: TMLR+VEGF group 49 6±11 5/mm 2 ,TMLR alone group 26 4±4 1/ mm 2; 8 weeks post therapy: TMLR+VEGF group 59 7±8 0/mm 2; TMLR alone group 28 7±2 9/mm 2). Conclusion Compared with TMLR alone, TMLR combined with VEGF gene therapy can enhance VEGF expression and further angiogenesis.